Variant report

Variant	rs2184061
Chromosome Location	chr9:22061562-22061563
allele	G/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr9:22061074..22062734-chr9:22066140..22068609,2	MCF-7	breast:

Extended variants
information (count: 53 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:48)

rs_ID	r²[population]
rs10115049	0.94[CHB][hapmap];0.82[JPT][hapmap]
rs10120688	0.85[ASN][1000 genomes]
rs10738605	0.80[ASN][1000 genomes]
rs10757264	0.94[CHB][hapmap];0.81[JPT][hapmap]
rs10757265	0.81[ASN][1000 genomes]
rs10757266	0.81[ASN][1000 genomes]
rs10757267	0.81[ASN][1000 genomes]
rs10811640	0.94[CHB][hapmap];0.82[JPT][hapmap]
rs10811643	0.94[CHB][hapmap];0.82[JPT][hapmap]
rs10811644	0.94[CHB][hapmap];0.82[JPT][hapmap]
rs10811648	0.86[AFR][1000 genomes];0.94[AMR][1000 genomes];0.96[EUR][1000 genomes]
rs10811649	0.86[AFR][1000 genomes];0.94[AMR][1000 genomes];0.96[EUR][1000 genomes]
rs10811651	0.83[AFR][1000 genomes];0.95[AMR][1000 genomes];0.96[EUR][1000 genomes]
rs10965212	0.94[CHB][hapmap];0.81[JPT][hapmap]
rs10965215	0.94[CHB][hapmap];0.81[JPT][hapmap]
rs10965219	0.81[ASN][1000 genomes]
rs10965223	0.87[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs10965224	0.82[AFR][1000 genomes];0.94[AMR][1000 genomes];0.96[EUR][1000 genomes]
rs1333036	0.81[ASN][1000 genomes]
rs1333039	0.87[AFR][1000 genomes];0.95[AMR][1000 genomes];0.97[EUR][1000 genomes]
rs1360589	0.83[EUR][1000 genomes]
rs1360590	1.00[CHB][hapmap];0.82[JPT][hapmap];0.81[ASN][1000 genomes]
rs1537378	0.85[AMR][1000 genomes];0.99[EUR][1000 genomes]
rs1591136	0.94[CHB][hapmap];0.82[JPT][hapmap]
rs2106119	0.88[CHB][hapmap];0.81[JPT][hapmap]
rs2106120	0.94[CHB][hapmap];0.82[JPT][hapmap]
rs2151280	0.89[CHB][hapmap]
rs2383204	0.81[ASN][1000 genomes]
rs2383205	0.85[AMR][1000 genomes];0.99[EUR][1000 genomes]
rs35307545	0.85[EUR][1000 genomes]
rs4645630	0.85[EUR][1000 genomes]
rs496892	0.94[CHB][hapmap];0.81[JPT][hapmap]
rs4977755	0.92[AMR][1000 genomes];0.97[EUR][1000 genomes]
rs4977756	0.82[AFR][1000 genomes];0.97[AMR][1000 genomes];0.96[EUR][1000 genomes]
rs643319	0.94[CHB][hapmap];0.81[JPT][hapmap]
rs6475604	0.84[EUR][1000 genomes]
rs7027048	0.81[ASN][1000 genomes]
rs7027950	0.81[ASN][1000 genomes]
rs7028570	0.81[ASN][1000 genomes]
rs7030641	0.84[EUR][1000 genomes]
rs7035484	0.94[CHB][hapmap];0.82[JPT][hapmap]
rs7044859	0.94[CHB][hapmap];0.81[JPT][hapmap]
rs7049105	0.94[CHB][hapmap];0.81[JPT][hapmap]
rs73446314	0.81[AFR][1000 genomes]
rs7866783	0.89[EUR][1000 genomes]
rs8181050	0.83[AMR][1000 genomes];0.98[EUR][1000 genomes]
rs944799	0.81[ASN][1000 genomes]
rs944801	0.84[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv529609	chr9:21708371-22537069	Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Bivalent/Poised TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
2	nsv8426	chr9:21763810-22176200	Weak transcription Strong transcription Active TSS Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	32 gene(s)	inside rSNPs	diseases
3	nsv1018514	chr9:21944275-22075326	Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Strong transcription Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
4	nsv892747	chr9:21984661-22068646	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Strong transcription Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
5	nsv531617	chr9:21985057-22809676	Genic enhancers Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	21 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:8 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:22053800-22065200	Weak transcription	NHEK	skin
2	chr9:22053800-22069000	Weak transcription	Hela-S3	cervix
3	chr9:22053800-22079800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr9:22054000-22064000	Weak transcription	Primary T killer memory cells from peripheral blood	blood
5	chr9:22055600-22079800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
6	chr9:22059200-22061800	Weak transcription	Dnd41	blood
7	chr9:22060000-22066400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
8	chr9:22060800-22061600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links